Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest Avapro Stories

2013-10-14 23:20:48

Reportbuyer.com just published a new market research report: Cardiovascular Disease: Recent Drug Advances and Impending Risks. London (PRWEB) October 14, 2013 There are nearly 300 medicines in clinical development to treat cardiovascular disease. This new research report examines in detail the key areas of the cardiovascular (CV) market, gathering inside opinion of cardiologists, to highlight the dynamic changes that are underway in this multibillion dollar marketplace. Successful...

2012-10-25 07:31:17

PARIS, Oct. 25, 2012 /PRNewswire/ -- Sanofi (NYSE: SNY; EURONEXT: SAN) Q3 2012 Change on a reported Change at 9-month 2012 Change on a reported basis basis Change at constant constant exchange rates(1)...

2012-10-12 15:22:15

PARSIPPANY, N.J., Oct. 12, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that its subsidiary Watson Laboratories, Inc. has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Irbesartan Tablets USP, 75 mg, 150 mg and 300 mg, the generic equivalent to Sanofi's Avapro(®). Watson intends to begin shipping the product immediately. Avapro(®) is indicated for the treatment of hypertension...

2012-07-26 02:29:02

PARIS, July 26, 2012 /PRNewswire/ -- Sanofi (NYSE: SNY; EURONEXT: SAN) Q2 2012 Change on a Change at H1 2012 Change on a Change at reported constant reported constant basis exchange rates(1) basis exchange rates ----- ---------------- ----- -------------- Net sales...

2012-04-27 02:25:48

PARIS, April 27, 2012 /PRNewswire/ -- (Logo: http://photos.prnewswire.com/prnh/20110616/NY20158LOGO ) Q1 2012 Change on a Change at constant reported basis exchange rates -------------- -------------- Net sales euro 8,511m +9.4% +7.0% Business net income(1) euro 2,442m +12.5% +8.4%...

2012-02-08 06:00:00

PARIS, Feb. 8, 2012 /PRNewswire/ -- (Logo : http://photos.prnewswire.com/prnh/20110616/NY20158LOGO ) Change at Change at Q4 2011 Change on a constant 2011 Change on a constant ------- ----------- --------- ---- ----------- --------- reported...